期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌保乳术后俯卧位放疗的研究 被引量：2

下载PDF
导出
摘要 乳腺癌的发病率位于女性常见恶性肿瘤的第二位[1].在美国,乳腺癌确诊后的15年生存率由2001年的58%上升至如今的75%[2],这不仅是由于乳腺癌早期确诊率的提高,更是治疗方法改进的结果[3,4].如今,针对早期乳腺癌患者进行保乳手术加术后放疗的治疗模式已被广泛接受和认可,而俯卧位放疗的出现使得治疗方式丰富.目前已有大量关于保乳术后俯卧位放疗的研究和分析结果被报道,俯卧位较之仰卧位放疗在剂量学方面有着一定的优势,但仍有一些不足之处和亟待解决的问题.
作者 陈昊 王凡
机构地区 芜湖市第二人民医院肿瘤科 安徽医科大学第一附属医院放疗科
出处 《安徽医学》 2013年第12期1886-1889,共4页 Anhui Medical Journal
关键词 乳腺癌 保乳手术 俯卧位 放疗
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献45

  • 1Fisher B,Anderson S,Bryant J. Twenty year follow up of a randomized trial comparing mastectomy,lumpectomy,and lumpectomy plus radiation for the treatment of invasive breastcancer[J].{H}New England Journal of Medicine,2002,(16):1233-1241.
  • 2National Home Office. Breast Cancer Facts and Figures 2009-2010[M].Atlanta:American Cancer Society.Inc,2009.8.
  • 3Clarke M,Collins R,Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival:An overview of the randomised trials[J].{H}LANCET,2005,(9503):2087-2106.
  • 4Early Breast Cancer Trialists′ Collaborative. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival:an overview of the randomised trials[J].{H}LANCET,2005,(9472):1687-1717.
  • 5Mustakallio S. Ber die Moglichkeiten der Rontgentherapie bei der Behandlung des Brustkrebses[J].{H}Acta Radiologica,1945,(06):503-522.
  • 6Gray JR,McCormick B,Cox L. Primary breast irradiation in large breasted or heavy women:analysis of cosmetic outcome[J].{H}International Journal of Radiation Oncology Biology Physics,1991,(02):347-354.
  • 7Merchant TE,McCormick B. Prone position breast irradia-tion[J].{H}International Journal of Radiation Oncology Biology Physics,1994,(01):197-203.
  • 8Lind PA,Pagnanelli R,Marks LB. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution[J].{H}International Journal of Radiation Oncology Biology Physics,2003,(04):914-920.
  • 9Correa CR,Litt HI,Hwang WT. Coronary artery findings after left sided compared with right sided radiation treatment for early stage breast cancer[J].{H}Journal of Clinical Oncology,2007,(21):3031-3037.
  • 10Inskip PD,Stovall M,Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1994,(13):983-988.

同被引文献28

  • 1甘霖.老年乳腺癌患者的治疗方案[J].中国老年学杂志,2015,35(1):245-246. 被引量：5
  • 2彭旭东,叶荣,吴琦.乳腺癌放疗摆位方法的改进[J].中华放射肿瘤学杂志,2006,15(3):156-156. 被引量：6
  • 3Downey L, Livingston R, Stopeck A. Diagnosing and treating breast cancer in elderly women:a call for improved understanding [ J ]. J Am Geriatr Soc ,2007,55 (10) : 1636-1644.
  • 4Blicherttoil M, Nielsen M, During M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast canc- er:20-year follow-up of the Danish randomized DBCG-82TM protocol [J]. Acta Oncol,2008,47(4) :672-681.
  • 5P Anand David, U Sara, K Manfred Borislav, et al. Morbidity after sen- tinel lymph node biopsy in primary breast cancer: results from a ran- domized controlled trial [ J ]. J Clin Onco1,2006,23 ( 19 ) :4312-4321.
  • 6Louwman WJ, Vulto JCM, Verhoeven RHA, et al. Clinical epidemiolo-gy of breast cancer in the elderly [ J ]. Eur J Cancer, 2007,43 ( 15 ) : 2242-2252.
  • 7Diab S, Elledge RG. Tumor characteristics and clinical outcome of elderly women with breast cancer[J]. J Natl Cancer Inst,2000,92 (7) :550-556.
  • 8R. L. Theriault. Disease free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of oper- able, node-positive, elderly breast cancer patients : 6-years follow up results of the French Adjuvant Study Group 08 trial [ J ]. J Clin On- col ,2005,16 ( 3 ) :278-279.
  • 9Jones SE, Savin MA, Holmes FA, et al. Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophos- phamide as adjuvant therapy for operable breast cancer [ J ]. J Clin Oneol,2006,24(34) :5381-5387.
  • 10Jones S, Holmes FJ, Blum J, et al. Docetaxel with eyclophoshpamide is associated witih an overall survival benefit compared with doxorubi- cin and eyelophosphamide:7-year follow-up of US oncology research trial 9735[J]. J Clin 0ne01,2009,27 (8) :1177-1183.

引证文献2

二级引证文献18

安徽医学
2013年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部